11 reports

Tel: + ##-##-##-## Fax: + ##-##-##-## Website: www. illumina. com ##. ##. ## OVERVIEW Illumina is one of the world leaders in sequencing and array based solutions for genetic analysis.

  • Oncology
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

New & Better Breast Imaging Technology Driving Lumpectomy Market ##. ## Digital Breast Tomosynthesis (DBT) ##. ## Breast Cancer Genetic Screening Tests on the Rise ##. ## FDA Approval of Innovative Lumpectomy Technology ##. ## Magnetic MaMaLoc Technology – Localized Lumpectomy Procedure ##.

  • Breast Cancer
  • General Medicine And Specialty Medicine
  • Oncology
  • United States

IN THIS REGARD, GRIFOLS DEVELOPED A CUTTING-EDGE GENETIC TEST THAT SIMULTANEOUSLY ANALYZES THE WORLD' S MOST PREVALENT MUTATIONS ASSOCIATED WITH DAAT, AN EFFORT LED BY PROGENIKA BIOPHARMA.

  • Oncology
  • Southern Europe
  • Spain
  • Forecast
  • Market Size

In Europe, the governments have set up few breast cancer screening programs (mammograms and genetic testing) to identify mutated genes BRCA (breast cancer) ## and ##.

  • Hospital
  • Oncology
  • Europe
  • Cianna Medical, Inc.
  • Hologic, Inc.

The dedicated cancer specialists in these centers ensure that women with breast cancer receive the required genetic testing, screening, and medical and paramedical advice.

  • Oncology
  • United States
  • Forecast
  • Carl Zeiss Meditec AG
  • Cianna Medical, Inc.
  • 5.2 MARKET DYNAMICS

HOWEVER, SOME GENETIC TESTS, ESPECIALLY THOSE THAT PREDICT THE RISK OF DEVELOPING A COMPLEX DISEASE CAUSED BY A COMBINATION OF ENVIRONMENTAL COMPONENTS AND GENETIC VARIATIONS, HAVE UNPROVEN CLINICAL UTILITY.

  • Oncology
  • North America
  • United States
  • Market Size
  • BTG plc

ALSO OF NOTE IS GRIFOLS' FDA-APPROVED GENETIC TEST FOR ALPHA-## DEFICIENCY AND PROLASTIN®-C LIQUID, RECENTLY INTRODUCED IN THE U. S.

  • Oncology
  • Southern Europe
  • Spain
  • Market Size
  • Grifols, S.A.

The prominent features of this report are - ##.

  • Clinical Trial
  • Lymphoma
  • Oncology
  • United States
  • World

The prominent features of this report are - ##.

  • Oncology
  • Therapy
  • World
  • Product Initiative
  • Celgene Corporation

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cell Therapy
  • Oncology
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer
  • Oncology
  • United States
  • World
  • Product Initiative